FDA Drug Application (022282) for ATAZANAVIR SULFATE AND RITONAVIR by MATRIX LABS LTD

Back to FDA Applications sponsored by MATRIX LABS LTD

Application Number022282
Product Number001
FormTABLET; ORAL
Dosage300MG/100MG
Product Market Status Tentative Approval
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameATAZANAVIR SULFATE AND RITONAVIR
Active IngredientATAZANAVIR SULFATE; RITONAVIR

Active IngredientCount
List of drugs with Active Ingredient ATAZANAVIR SULFATE6
List of drugs with Active Ingredient RITONAVIR11


Back to FDA Applications sponsored by MATRIX LABS LTD